1. Home
  2. GOSS vs RBBN Comparison

GOSS vs RBBN Comparison

Compare GOSS & RBBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • RBBN
  • Stock Information
  • Founded
  • GOSS 2015
  • RBBN 1997
  • Country
  • GOSS United States
  • RBBN United States
  • Employees
  • GOSS N/A
  • RBBN N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • RBBN EDP Services
  • Sector
  • GOSS Health Care
  • RBBN Technology
  • Exchange
  • GOSS Nasdaq
  • RBBN Nasdaq
  • Market Cap
  • GOSS 585.9M
  • RBBN 671.1M
  • IPO Year
  • GOSS 2019
  • RBBN 2000
  • Fundamental
  • Price
  • GOSS $2.41
  • RBBN $3.92
  • Analyst Decision
  • GOSS Strong Buy
  • RBBN Strong Buy
  • Analyst Count
  • GOSS 6
  • RBBN 4
  • Target Price
  • GOSS $8.60
  • RBBN $6.00
  • AVG Volume (30 Days)
  • GOSS 3.7M
  • RBBN 511.6K
  • Earning Date
  • GOSS 11-06-2025
  • RBBN 10-22-2025
  • Dividend Yield
  • GOSS N/A
  • RBBN N/A
  • EPS Growth
  • GOSS N/A
  • RBBN N/A
  • EPS
  • GOSS N/A
  • RBBN N/A
  • Revenue
  • GOSS $40,237,000.00
  • RBBN $863,459,000.00
  • Revenue This Year
  • GOSS N/A
  • RBBN $7.26
  • Revenue Next Year
  • GOSS $34.10
  • RBBN $5.52
  • P/E Ratio
  • GOSS N/A
  • RBBN N/A
  • Revenue Growth
  • GOSS N/A
  • RBBN 7.68
  • 52 Week Low
  • GOSS $0.66
  • RBBN $3.01
  • 52 Week High
  • GOSS $3.60
  • RBBN $5.38
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 44.51
  • RBBN 55.84
  • Support Level
  • GOSS $2.25
  • RBBN $3.63
  • Resistance Level
  • GOSS $2.61
  • RBBN $3.98
  • Average True Range (ATR)
  • GOSS 0.18
  • RBBN 0.11
  • MACD
  • GOSS -0.05
  • RBBN 0.01
  • Stochastic Oscillator
  • GOSS 24.58
  • RBBN 88.00

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

Share on Social Networks: